healthcare News
Senseonics Surges on Major Q4 Revenue Beat, Strong 2026 Outlook
The diabetes tech firm's preliminary revenue beat estimates by over 78%, signaling growing traction for its long-term implantable glucose monitor.
BioLife Solutions Misses Q4 Revenue Due to Pull-Forward, Beats Full-Year Target
The biopreservation tool supplier reported 20% year-over-year quarterly growth and record full-year sales, citing a customer request for an earlier shipment for the fourth-quarter miss.
Cerus Corp Lifts 2026 Forecast on Strong Blood Product Demand
Biomedical firm posts 14% revenue growth in preliminary 2025 results, beating Q4 estimates and signaling continued momentum for its blood safety system.
Harmony Biosciences Jumps After Strong 2026 WAKIX Revenue Forecast
The biotech company projects its key narcolepsy drug, WAKIX, will surpass $1 billion in annual revenue, signaling robust long-term growth and boosting investor confidence.
AtriCure Jumps After Strong Revenue Beat, New Credit Facility
The medical device maker announced preliminary Q4 revenue ahead of estimates and secured a new $125 million credit agreement, signaling strong operational and financial health.
Dexcom Dips Despite Q4 Beat as 2026 Outlook Signals Slower Growth
The continuous glucose monitor maker's full-year forecast of 11-13% growth falls short of some analyst expectations, overshadowing a strong quarterly performance.
OrthoPediatrics Slips as Q4 Revenue Miss Overshadows Strong 2026 Forecast
Shares fall despite the medical device maker projecting double-digit growth and $25 million in adjusted EBITDA, signaling investor concern over the near-term sales shortfall.
Esperion Surges After Forecasting Up to 38% Revenue Growth
Company projects strong 2025 sales for its cholesterol-lowering drugs, citing momentum from an expanded FDA label and robust prescription uptake.